申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US04866091A1
公开(公告)日:1989-09-12
This invention relates to new alkane-sulfonanilide derivatives of the formula: ##STR1## wherein R.sup.1, R.sup.2 and R.sup.8 are each hydrogen, cyano, halogen, lower alkyl, halo (lower) alkyl, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl or lower alkoxy, R.sup.3 is lower alkyl, R.sup.4 is acyl, cyano, carboxy, hydroxy(lower)-alkyl, mercapto, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, 5-membered unsaturated heterocyclic group which may have amino, lower alkanoylamino, lower alkylthio or lower alkylsulfonyl, phenylthio which may have nitro or amino, lower alkanoyl(lower)alkenyl or a group of the formula: ##STR2## wherein R.sup.6 is hydrogen, amino or lower alkyl and R.sup.7 is hydroxy, lower alkoxy, carboxy(lower)alkoxy, lower alkoxycarbonyl(lower)alkoxy, ureido or thioureido, and R.sup.5 is hydrogen, halogen, lower alkyl or lower alkanoyl, and pharmaceutically acceptable salts thereof. More particularly, it relates to alkanesulfonanilide derivatives and pharmaceutically acceptable salts thereof which have antiinflammatory activities and analgesic activities, to processes for the preparation thereof, to a pharmaceutical composition comprising the same and to a method for the treatment of inflammatory disease or pains in human being and animals".
该发明涉及一种新的烷基磺酰基苯胺衍生物,其化学式为:##STR1## 其中R.sup.1、R.sup.2和R.sup.8各自为氢、氰基、卤素、较低的烷基、卤代(较低的)烷基、较低的烷基硫醇基、较低的烷基亚砜基、较低的烷基磺酰基或较低的烷氧基,R.sup.3为较低的烷基,R.sup.4为酰基、氰基、羧基、羟基(较低)烷基、巯基、较低的烷基硫醇基、较低的烷基亚砜基、较低的烷基磺酰基、5-成员不饱和杂环基,该基团可以具有氨基、较低的烷酰胺基、较低的烷基硫醇基或较低的烷基磺酰基、苯基硫醇基,该苯基硫醇基可以具有硝基或氨基、较低的烷酰基(较低)烯基或化学式的基团:##STR2## 其中R.sup.6为氢、氨基或较低的烷基,R.sup.7为羟基、较低的烷氧基、羧基(较低)烷氧基、较低的烷氧羰基(较低)烷氧基、脲基或硫脲基,R.sup.5为氢、卤素、较低的烷基或较低的烷酰基,以及其药学上可接受的盐。更具体地说,它涉及具有抗炎活性和镇痛活性的烷基磺酰基苯胺衍生物和药学上可接受的盐,以及其制备方法、包括它们的制药组合物和用于治疗人和动物的炎症性疾病或疼痛的方法。